Home
Click

Centre for Cancer Biomarkers CCBIO

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine and Dentistry, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine.

Project managers
CCBIO has eight principal investigators, and three associated investigators:

CCBIO Annual Symposium 2017

Inspiration for cancer researchers at Solstrand

The Centre for Cancer Biomarkers CCBIO met for the 5th time at their Annual Symposium at Solstrand 19-20 April. "We wish to motivate, especially the younger researchers, to perform excellent cancer research," says Center Director Lars A. Akslen.

book release

First CCBIO book release

The ethics, economics and ELSA research groups of CCBIO are coordinating their research activities ever more. In April they published their first joint book volume "Cancer Biomarkers: Ethics, Economics and Society".

News

Alumnus of the Month: Lars A Akslen

«Seek international experiences !» recommends CCBIO Director Lars A. Akslen to the students of today.

News

The CCBIO Annual Report 2016 is available

Now you can read the brand new CCBIO Annual Report 2016!

News

Award to CCBIO PhD candidate Emilia Hugdahl

Congratulations to Emilia Hugdahl for the YDF-award from the Norwegian Society of Dermatology and Venereology!

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.